Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,133 INR | +3.26% | +14.12% | +12.40% |
04-25 | GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology | RE |
03-22 | GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities | CI |
Chart calendar GlaxoSmithKline Pharmaceuticals Limited
Upcoming events on GlaxoSmithKline Pharmaceuticals Limited
Past events on GlaxoSmithKline Pharmaceuticals Limited
15/02/2024 10:30 | Investor Meeting |
12/02/2024 11:25 | Q3 2024 Earnings Release |
23/11/2023 | Investor Meeting |
09/11/2023 11:05 | Q2 2024 Earnings Release |
16/08/2023 | Analyst Meeting - Birla Sunlife MF |
26/07/2023 10:00 | Annual General Meeting |
26/07/2023 09:15 | Q1 2024 Earnings Release |
29/06/2023 | Ex-dividend day for final dividend |
08/06/2023 | Investor Meeting - HDFC Life Insurance Company Limited |
08/06/2023 | Investor Meeting - Investor Meeting Mutual Fund |
17/05/2023 12:23 | Q4 2023 Earnings Release |
16/03/2023 11:00 | Investor Meeting |
07/02/2023 10:40 | Q3 2023 Earnings Release |
11/11/2022 10:38 | Interim 2023 Earnings Release |
23/08/2022 11:30 | Analyst Meeting |
26/07/2022 09:00 | Annual General Meeting |
25/07/2022 15:44 | Q1 2023 Earnings Release |
06/07/2022 | Ex-dividend day for final dividend |
06/07/2022 | Ex-dividend day for extraordinary dividend |
16/05/2022 12:05 | FY 2022 Earnings Release |
Past dividends on GlaxoSmithKline Pharmaceuticals Limited
29/06/2023 | Annual 32 INR |
06/07/2022 | Annual 30 INR |
06/07/2022 | Bonus Payment 60 INR |
18/07/2021 | Annual 30 INR |
16/07/2020 | Annual 20 INR |
16/07/2020 | Bonus Payment 20 INR |
10/07/2019 | Annual 20 INR |
12/07/2018 | Annual 35 INR |
13/07/2017 | Annual 30 INR |
14/07/2016 | Annual 50 INR |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 31 281 32 559 -3.93% | 32 244 32 844 -1.83% | 31 989 32 599 -1.87% | 32 780 34 314 -4.47% | 32 517 33 026 -1.54% | 33 649 |
EBITDA Million INR | Released Forecast Spread | 6 008 6 170 -2.62% | 6 573 6 522 0.77% | 6 953 7 174 -3.08% | 8 273 8 140 1.64% | 8 043 8 279 -2.85% | 8 671 |
EBIT Million INR | Released Forecast Spread | 5 522 5 800 -4.8% | 5 746 6 114 -6.02% | 6 161 6 667 -7.59% | 7 592 7 506 1.14% | 7 385 7 769 -4.93% | 8 450 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 6 827 6 262 9.02% | 3 058 2 898 5.5% | 5 505 7 095 -22.41% | 7 791 13 406 -41.89% | 8 364 8 191 2.11% | 9 325 |
Net income Million INR | Released Forecast Spread | 4 454 4 274 4.2% | 932 858 8.6% | 3 582 5 195 -31.05% | 16 947 11 084 52.9% | 6 107 6 224 -1.88% | 6 063 |
EPS INR | Released Forecast Spread | 26,3 24,4 7.9% | 5,50 14,6 -62.37% | 21,1 30,9 -31.65% | 100 61,9 61.62% | 36,1 37,1 -2.82% | 40,2 |
Announcement Date | 20/05/19 | 18/05/20 | 18/05/21 | 16/05/22 | 17/05/23 | - |
Quarterly results
Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 8 138 8 315 -2.13% | 7 900 8 202 -3.69% | 10 099 9 507 6.23% | 8 159 9 282 -12.09% | 8 096 8 734 -7.3% | 7 451 8 412 -11.43% | 9 169 9 802 -6.46% | 8 023 8 681 -7.58% | 7 875 8 176 -3.69% | 7 617 7 662 -0.6% | 9 129 | 8 555 | 8 396 |
EBITDA Million INR | Released Forecast Spread | 1 709 1 837 -6.96% | 1 517 1 800 -15.75% | 2 765 2 157 28.18% | 1 978 2 059 -3.94% | 1 752 1 990 -11.96% | 1 489 1 857 -19.82% | 2 569 2 429 5.76% | 2 287 2 264 1.01% | 1 697 1 863 -8.89% | 1 439 1 647 -12.65% | 2 351 | 2 354 | 2 098 |
EBIT Million INR | Released Forecast Spread | 1 530 1 496 2.3% | 1 340 1 551 -13.63% | 2 589 2 169 19.37% | 1 799 1 898 -5.19% | 1 599 1 998 -19.98% | 1 331 1 770 -24.8% | 2 406 2 323 3.56% | 2 123 1 926 10.22% | 1 526 2 291 -33.41% | 1 275 1 764 -27.71% | 2 339 | 2 049 | 1 898 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 630 1 675 -62.38% | 1 649 1 726 -4.46% | 2 735 2 312 18.31% | 1 718 2 054 -16.38% | 2 079 2 065 0.65% | 1 600 1 919 -16.61% | 2 622 2 480 5.71% | 2 243 2 116 5.98% | 1 900 2 437 -22.05% | 1 810 1 991 -9.1% | 2 701 | 2 327 | 2 168 |
Net income Million INR | Released Forecast Spread | 143 1 262 -88.65% | 1 211 1 276 -5.11% | 2 042 1 585 28.9% | 1 504 1 436 4.7% | 12 191 1 672 629.1% | 1 193 1 523 -21.68% | 1 934 1 908 1.4% | 1 646 1 648 -0.17% | 1 334 1 383 -3.49% | 1 323 1 202 10.02% | 1 998 | 1 295 | 1 610 |
EPS INR | Released Forecast Spread | 0,85 9,24 -90.8% | 7,15 8,89 -19.57% | 12,1 8,50 41.97% | 8,88 9,25 -4% | 72,0 10,3 596.61% | 7,04 9,30 -24.3% | 11,4 10,1 12.62% | 9,71 10,0 -3.33% | 7,88 11,3 -30.2% | ||||
Announcement Date | 18/05/21 | 26/07/21 | 29/10/21 | 07/02/22 | 16/05/22 | 25/07/22 | 11/11/22 | 07/02/23 | 17/05/23 | 26/07/23 | - | - | - |
Past sector events for GlaxoSmithKline Pharmaceuticals Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLAXO Stock
- Calendar GlaxoSmithKline Pharmaceuticals Limited